| | | ASPARTAME 92 REPORTED SYMPTOMS |  | | | | | | IN A REPORT DATED APRIL 20, 1995, WRITTEN WITH THE LETTERHEAD OF THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES, THE REPORT ENTITLED "SYMPTOMS ATTRIBUTED TO ASPARTAME IN COMPLAINTS SUBMITTED TO THE FDA", THE FOLLOWING SYMPTOMS ARE LISTED. NOTE THAT THERE ARE TWO REPORTS HERE. THE FIRST REPORT LISTS SYMPTOMS REPORTED OVER 100 TIMES AND LUMPS THE REMAINDER TOGETHER UNDER THE HEADING OF "SYMPTOMS REPORTED BY LESS THAN 100 COMPLAINTS". THE NEXT REPORT LISTS 92 SEPARATE SYMPTOMS, AS CATEGORIZED BY THE FDA ACCORDING TO THEIR CRITERIA IN CATEGORIZING SUCH COMPLAINTS. ONE RESULT OF THIS CATALOGING IS THAT SEIZURES - ONE MAJOR CONCERN ASSOCIATED WITH ASPARTAME CONSUMPTION, ARE BROKEN DOWN INTO AT LEAST FIVE DIFFERENT CATEGORIES. THUS WE HAVE LISTED 291 REPORTS OF "SEIZURES AND CONVULSIONS", 174 REPORTS OF "GRAND MAL", 26 REPORTS OF "PETIT MAL", 10 REPORTS OF "SIMPLE PARTIAL SEIZURES", AND 4 REPORTS OF "COMPLEX PARTIAL SEIZURES". THIS RAISES THE NUMBER OF REPORTS WHICH MIGHT BE CLASSIFIED AS "SEIZURES AND CONVULSIONS" TO AT LEAST 505, MAKING THOSE REPORTS INTO AROUND 19.4% OF THE TOTAL REPORTS FILED IN THIS PARTICULAR COLLECTION OF COMPLAINTS. ANOTHER NOTABLE ELEMENT IS THAT IN THE FIRST REPORT, HEADACHES ARE LISTED AS HAVING BEEN REPORTED 1847 TIMES AND IN THE SECOND REPORT 1862 TIMES. WE DO NOT KNOW WHAT THE EXPLANATION FOR THAT DISCREPANCY IS. THIS REPORT WAS GOTTEN WITH THE AID OF THE FREEDOM OF INFORMATION ACT. THE FDA DID NOT WANT TO GIVE IT UP FREELY OR EVEN ACKNOWLEDGE ITS EXISTENCE. | | |
| | | | REPORTED SYMPTOMS | NO. OF COMPLAINTS | % OF REPORTS | % OF COMPLAINTS | | HEADACHE | 1847 | 21.1% | 19.0% | | DIZZINESS/POOR EQUALIBRIUM | 735 | 11.2% | 7.5% | | CHANGE OF MOOD | 656 | 10.0% | 6.7% | | VOMITING OR NAUSEA | 647 | 9.8% | 6.6% | | ABDOMINAL PAIN AND CRAMPS | 483 | 6.9% | 4.7% | | CHANGE IN VISION | 362 | 5.5% | 3.7% | | DIARRHEA | 330 | 5.0% | 3.4% | | SEIZURES AND CONVULSIONS | 290 | 4.4% | 3.0% | | MEMORY LOSS | 255 | 3.9% | 2.6% | | FATIGUE,WEAKNESS | 242 | 3.7% | 2.5% | | OTHER NEUROLOGICAL | 230 | 3.5% | 2.4% | | RASH | 226 | 3.4% | 2.3% | | SLEEP PROBLEMS | 201 | 3.1% | 2.1% | | HIVES | 191 | 2.9% | 2.0% | | CHANGE IN HEART RATE | 185 | 2.8% | 1.9% | | ITCHING | 175 | 2.7% | 1.8% | | GRAN MAL | 174 | 2.6% | 1.8% | | NUMBNESS, TINGLING | 172 | 2.6% | 1.8% | | LOCAL SWELLING | 114 | 1.7% | 1.2% | | | | CHANGE IN ACTIVITY LEVEL | 113 | 1.7% | 1.2% | | DIFFICULTY BREATHING | 112 | 1.7% | 1.2% | | ORAL SENSORY CHANGES | 108 | 1.6% | 1.1% | | CHANGE IN MENSTRUAL PATTERN | 107 | 1.6% | 1.1% | | SYMPTOMS REPORTED BY LESS THAN 100 COMPLAINTS | 1812 | -------- | 18.6% | | | |
| | | THE FOLLOWING IS THE COMPLETE LIST OF ALL 92 SYMPTOMS REPORTED TO THE FDA IN 1995, LISTED IN ORDER OF VOLUME OF REPORTS. - 1862 28.28% 19.03% HEADACHE
- 737 11.19% 7.53% DIZZINESS OR PROBLEMS WITH BALANCE
- 656 9.96% 6.70% CHANGE IN MOOD QUALITY OR LEVEL
- 651 9.88% 6.65% VOMITING AND NAUSEA
- 457 6.94% 4.67% ABDOMINAL PAINS AND CRAMPS
- 364 5.52% 3.72% CHANGE IN VISION
- 331 5.02% 3.38% DIARRHEA
- 291 4.42% 2.97% SEIZURES AND CONVULSIONS
- 256 3.88% 2.61% MEMORY LOSS
- 242 3.67% 2.47% FATIGUE, WEAKNESS
- 230 3.49% 2.35% OTHER NEUROLOGICAL
- 226 3.43% 2.31% RASH
- 201 3.05% 2.05% SLEEP PROBLEMS
- 191 2.90% 1.95% HIVES
- 186 2.82% 1.90% CHANGE IN HEART RATE
- 175 2.65% 1.78% ITCHING
- 174 2.64% 1.77% CHANGE IN SENSATION (NUMBNESS, TINGLING)
- 174 2.64% 1.77% GRAND MAL
- 115 1.74% 1.17% LOCAL SWELLING
- 114 1.73% 1.16% CHANGE IN ACTIVITY LEVEL
- 112 1.70% 1.24% DIFFICULTY BREATHING
- 108 1.64% 1.10% ORAL SENSORY CHANGES
- 107 1.62% 1.09% CHANGE IN MENSTRUAL PATTERN
- 100 1.51% 1.02% OTHER SKIN
- 98 1.48% 1.00% OTHER
| | |
Free Forum Hosting
Important Announcement
Recommend
First 